Literature DB >> 30062664

The experience with transsphenoidal surgery and its importance to outcomes.

Jürgen Honegger1, Florian Grimm2.   

Abstract

PURPOSE: Surgical experience is considered paramount for excellent outcome of transsphenoidal surgery (TSS). However, objective data demonstrating the surgical success in relation to the experience of pituitary surgery units or individual experience of pituitary surgeons is sparse.
METHODS: Based on literature data, we have investigated the influence of experience with TSS for pituitary adenomas on endocrinological remission rates and on operative complications. The surgical experience was assessed by calculating the number of transsphenoidal operations per year.
RESULTS: For TSS of microprolactinomas, mean remission rates were 77% in centers with < 2 operations per year for microprolactinomas, 82% with 2-4 operations, 84% with 4-6 operations, and 91% with > 6 operations. A yearly experience with more than 10 initial operations for Cushing's disease (CD) warrants a remission rate exceeding 70%. Remission rates in CD exceeding 86% have only been reported for single surgeon series. Extraordinarily high complication rates were found in some series with < 25 yearly total operations for pituitary adenomas. Major vascular complications were less than 2% and revision rates for rhinorrhea usually < 2.5% in centers performing > 25 transsphenoidal operations per year.
CONCLUSIONS: We conclude that a center with experience of > 25 transsphenoidal operations for pituitary adenomas per year provides a high likelihood of safe TSS. Surgery for CD requires a particularly high level of practice to guarantee excellent remission rates. The endocrinologist has the unique opportunity to audit the surgical success by hormone measurement and to refer patients to neurosurgeons with proven excellence.

Entities:  

Keywords:  Complications; Cushing’s disease; Pituitary adenoma; Remission rate; Surgical experience; Transsphenoidal surgery

Mesh:

Substances:

Year:  2018        PMID: 30062664     DOI: 10.1007/s11102-018-0904-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  127 in total

1.  Cushing's disease: results of treatment and factors affecting outcome.

Authors:  Ariachery C Ammini; Saptarshi Bhattacharya; Jaya Praksh Sahoo; Jim Philip; Nikhil Tandon; Ravinder Goswami; Viveka J Jyotsna; Rajesh Khadgawat; Sunil Chumber; Aashu Seth; Asis K Karak; Bhawani S Sharma; Poodipedi Sarat Chandra; Ashish Suri; Manish S Sharma; Shashank S Kale; Manmohan Singh
Journal:  Hormones (Athens)       Date:  2011 Jul-Sep       Impact factor: 2.885

2.  Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients.

Authors:  Jackson A Gondim; Joao Paulo C Almeida; Lucas Alverne F Albuquerque; Michele Schops; Erika Gomes; Tania Ferraz; Wladia Sobreira; Meissa T Kretzmann
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

3.  Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.

Authors:  Marc Mayberg; Stephen Reintjes; Anika Patel; Kelley Moloney; Jennifer Mercado; Alex Carlson; James Scanlan; Frances Broyles
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

4.  Transsphenoidal surgery assisted by a new guidance device: results of a series of 747 cases.

Authors:  Yang Tao; Gu Jian-wen; Kuang Yong-qin; Yang Li-bin; Huang Hai-dong; Yang Wen-tao; Xing Xue-min
Journal:  Clin Neurol Neurosurg       Date:  2011-05-20       Impact factor: 1.876

5.  Transition From Microscopic to Endoscopic Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas.

Authors:  Atte Karppinen; Leena Kivipelto; Satu Vehkavaara; Elina Ritvonen; Emmi Tikkanen; Riku Kivisaari; Juha Hernesniemi; Kirsi Setälä; Camilla Schalin-Jäntti; Mika Niemelä
Journal:  World Neurosurg       Date:  2015-02-28       Impact factor: 2.104

6.  Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases.

Authors:  Xin Qu; Min Wang; Guodong Wang; Tao Han; Chengzhi Mou; Lizhang Han; Meng Jiang; Yuanming Qu; Miao Zhang; Qi Pang; Guangming Xu
Journal:  Eur J Endocrinol       Date:  2011-01-20       Impact factor: 6.664

7.  Three-Hand Endoscopic Endonasal Transsphenoidal Surgery: Experience With an Anatomy-Preserving Mononostril Approach Technique.

Authors:  Chikezie I Eseonu; Karim ReFaey; Eva Pamias-Portalatin; Javier Asensio; Oscar Garcia; Kofi D Boahene; Alfredo Quiñones-Hinojosa
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-02-01       Impact factor: 2.703

8.  Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases.

Authors:  Charlotte Höybye; Eva Grenbäck; Marja Thorén; Anna-Lena Hulting; Lars Lundblad; Hans von Holst; Anders Anggård
Journal:  J Neurosurg       Date:  2004-04       Impact factor: 5.115

9.  Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.

Authors:  Martin Hlavica; David Bellut; Doreen Lemm; Christoph Schmid; René Ludwig Bernays
Journal:  World Neurosurg       Date:  2012-10-05       Impact factor: 2.104

10.  Nonfunctioning Pituitary Adenomas Are Really Clinically Nonfunctioning? Clinical and Endocrinological Symptoms and Outcomes with Endoscopic Endonasal Treatment.

Authors:  Ali Erdem Yildirim; Mert Sahinoglu; Ibrahim Ekici; Emin Cagil; Derya Karaoglu; Haydar Celik; Osman Arıkan Nacar; Ahmed Deniz Belen
Journal:  World Neurosurg       Date:  2015-09-04       Impact factor: 2.104

View more
  19 in total

Review 1.  The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Authors:  Pietro Mortini; Gianluca Nocera; Francesca Roncelli; Marco Losa; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 2.  Surgery for prolactinomas: a better choice?

Authors:  Jürgen Honegger; Isabella Nasi-Kordhishti; Nuran Aboutaha; Sabrina Giese
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

Review 3.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

Review 4.  Multidisciplinary management of acromegaly: A consensus.

Authors:  Andrea Giustina; Garni Barkhoudarian; Albert Beckers; Anat Ben-Shlomo; Nienke Biermasz; Beverly Biller; Cesar Boguszewski; Marek Bolanowski; Jens Bollerslev; Vivien Bonert; Marcello D Bronstein; Michael Buchfelder; Felipe Casanueva; Philippe Chanson; David Clemmons; Maria Fleseriu; Anna Maria Formenti; Pamela Freda; Monica Gadelha; Eliza Geer; Mark Gurnell; Anthony P Heaney; Ken K Y Ho; Adriana G Ioachimescu; Steven Lamberts; Edward Laws; Marco Losa; Pietro Maffei; Adam Mamelak; Moises Mercado; Mark Molitch; Pietro Mortini; Alberto M Pereira; Stephan Petersenn; Kalmon Post; Manuel Puig-Domingo; Roberto Salvatori; Susan L Samson; Ilan Shimon; Christian Strasburger; Brooke Swearingen; Peter Trainer; Mary L Vance; John Wass; Margaret E Wierman; Kevin C J Yuen; Maria Chiara Zatelli; Shlomo Melmed
Journal:  Rev Endocr Metab Disord       Date:  2020-09-10       Impact factor: 6.514

Review 5.  Surgical and radiosurgical treatment strategies for Cushing's disease.

Authors:  Adomas Bunevicius; Edward R Laws; Mary Lee Vance; Sherry Iuliano; Jason Sheehan
Journal:  J Neurooncol       Date:  2019-11-01       Impact factor: 4.130

6.  Equivalent outcomes in nasal symptoms following microscopic or endoscopic transsphenoidal surgery: results from multi-centre, prospective study.

Authors:  Charlie Osborne; Daniel Lewis; Ben Dixon; Carmela Caputo; Alison Magee; Kanna Gnanalingham; Yi Yuen Wang
Journal:  Acta Neurochir (Wien)       Date:  2022-02-08       Impact factor: 2.816

7.  Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas.

Authors:  Ji Yong Park; Wonsuk Choi; A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Woo-Youl Jang; Shin Jung; Ho-Cheol Kang
Journal:  Pituitary       Date:  2021-06-29       Impact factor: 4.107

8.  Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score.

Authors:  Mendel Castle-Kirszbaum; Peter Fuller; Yi Yuen Wang; James King; Tony Goldschlager
Journal:  Pituitary       Date:  2021-05-26       Impact factor: 4.107

Review 9.  Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.

Authors:  Leah T Braun; German Rubinstein; Stephanie Zopp; Frederick Vogel; Christine Schmid-Tannwald; Montserrat Pazos Escudero; Jürgen Honegger; Roland Ladurner; Martin Reincke
Journal:  Endocrine       Date:  2020-08-02       Impact factor: 3.633

10.  Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients.

Authors:  Jai Deep Thakur; Alex Corlin; Regin Jay Mallari; Samantha Yawitz; Amalia Eisenberg; Walavan Sivakumar; Chester Griffiths; Ricardo L Carrau; Sarah Rettinger; Pejman Cohan; Howard Krauss; Katherine A Araque; Garni Barkhoudarian; Daniel F Kelly
Journal:  Pituitary       Date:  2021-07-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.